From: Potential mechanisms of resistance to venetoclax and strategies to circumvent it
 | Cell Lines | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary Sequence Name | OCI-Ly1 parent | OCI-Ly1 199R | SC-1 parent | SC-1 199R | HBL1 parent | HBL1 199R | U2932 Parent | U2932 199R | RS4;11 parent | RS4;11 199R | HBL2 parent | HBL2 199R | Granta-519 parent | Granta-519 199R |
BCL2 | 0.46 | 0.46 | 6.00 | 7.79 | 3.01 | 3.19 | 14.86 | 7.08 | 2.05 | 1.97 | 6.07 | 1.34 | 5.99 | 5.61 |
BCL2L1 | 2.08 | 2.27 | 2.17 | 9.16 | 2.08 | 2.03 | 2.09 | 2.14 | 2.06 | 2.05 | 1.93 | 1.99 | 1.83 | 1.85 |
MCL1 | 2.07 | 3.21 | 2.18 | 5.12 | 2.11 | 2.04 | 9.99 | 11.25 | 2.16 | 2.10 | 2.99 | 1.96 | 2.39 | 2.40 |
BCL2A1 | 2.04 | 2.08 | 2.10 | 2.07 | 2.08 | 2.03 | 3.05 | 2.88 | 2.00 | 2.03 | 1.91 | 1.91 | 2.33 | 2.05 |
BCL2L2 | 2.06 | 2.15 | 2.11 | 2.10 | 2.08 | 2.05 | 2.08 | 2.10 | 2.18 | 2.14 | 1.95 | 1.99 | 1.30 | 1.29 |
BAX | 2.09 | 2.22 | 2.18 | 2.00 | 2.17 | 2.04 | 3.12 | 2.92 | 2.17 | 2.18 | 2.06 | 1.99 | 2.48 | 2.43 |
BAK1 | 2.06 | 2.17 | 2.23 | 2.12 | 1.13 | 1.01 | 2.16 | 2.16 | 2.12 | 2.11 | 2.02 | 2.10 | 1.94 | 1.93 |
BID | 2.07 | 2.23 | 2.30 | 2.18 | 2.21 | 2.08 | 2.18 | 2.05 | 2.24 | 2.20 | 2.04 | 2.11 | 1.98 | 2.13 |
BCL2L11 | 2.02 | 2.10 | 2.46 | 2.02 | 2.10 | 0.46 | 1.13 | 2.01 | 1.99 | 1.99 | 1.97 | 2.21 | 1.93 | 2.12 |
PMAIP1 | 1.99 | 1.55 | 3.07 | 2.26 | 3.12 | 3.15 | 18.25 | 9.50 | 2.05 | 1.97 | 3.76 | 1.26 | 6.22 | 5.61 |
BBC3 | 2.09 | 2.22 | 2.24 | 2.00 | 2.17 | 2.04 | 3.12 | 2.92 | 2.17 | 2.18 | 2.06 | 1.99 | 2.41 | 2.43 |
BAD | 2.01 | 2.11 | 2.36 | 2.18 | 2.07 | 2.05 | 2.11 | 2.07 | 2.12 | 2.12 | 2.05 | 2.00 | 1.86 | 1.60 |